• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强肝脏MRI上肝血管瘤的强化模式及假性廓清

Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.

作者信息

Kim Bohyun, Byun Jae Ho, Kim Hyoung Jung, Won Hyung Jin, Kim So Yeon, Shin Yong Moon, Kim Pyo Nyun

机构信息

Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Asanbyeongwon-gil 86, Songpa-Gu, Seoul, 138-736, Korea.

Department of Radiology, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon, 443-380, Korea.

出版信息

Eur Radiol. 2016 Jan;26(1):191-8. doi: 10.1007/s00330-015-3798-9. Epub 2015 May 2.

DOI:10.1007/s00330-015-3798-9
PMID:25933742
Abstract

OBJECTIVES

To compare the enhancement patterns and prevalence of pseudo-washout between rapidly and slowly enhancing hepatic haemangiomas on gadoxetate disodium-enhanced MRI in patients with chronic liver disease (CLD) and healthy liver (HL).

METHODS

On gadoxetate disodium-enhanced MRI, the extent of intralesional arterial enhancement >50 % and ≤ 50 % of lesions was defined as rapid and slow enhancement, respectively. The enhancement patterns and presence of pseudo-washout during the portal venous phase (PVP) and transitional phase (TP) of 74 hepatic haemangiomas were retrospectively evaluated in the CLD and HL groups. Sequential changes of signal-to-noise ratio (SNR) were measured in unenhanced phase, PVP and TP.

RESULTS

Irrespective of hepatic health status, pseudo-washout in TP was significantly more common in the rapidly enhancing haemangiomas (p ≤ 0.026). In both groups, rapidly enhancing haemangiomas showed complete or progressive incomplete enhancement in PVP, which either lasted or transformed to pseudo-washout in TP, whereas slowly enhancing haemangiomas showed progressive incomplete enhancement in PVP and TP. SNR of hepatic parenchyma continued to rise until TP, whereas that of portal vein and haemangioma falls in TP.

CONCLUSIONS

Regardless of CLD, pseudo-washout in TP was more common in rapidly than in slowly enhancing haemangiomas, with enhancement patterns differing in the two subgroups.

KEY POINTS

On gadoxetate disodium-enhanced MRI, some hepatic haemangiomas show pseudo-washout in transitional phase. Regardless of chronic liver disease, pseudo-washout is significantly more common in rapidly enhancing haemangiomas. Rapidly enhancing haemangiomas show complete or progressive incomplete enhancement or pseudo-washout in TP. Slowly enhancing haemangiomas show progressive incomplete enhancement in portal venous phase and TP.

摘要

目的

比较慢性肝病(CLD)患者和健康肝脏(HL)患者在钆塞酸二钠增强MRI上快速强化和缓慢强化的肝血管瘤之间的强化模式及伪廓清发生率。

方法

在钆塞酸二钠增强MRI上,病灶内动脉期强化程度>50%和≤50%分别定义为快速强化和缓慢强化。回顾性评估CLD组和HL组中74个肝血管瘤在门静脉期(PVP)和移行期(TP)的强化模式及伪廓清情况。在平扫期、PVP和TP期测量信噪比(SNR)的连续变化。

结果

无论肝脏健康状况如何,快速强化的血管瘤在TP期出现伪廓清的情况明显更常见(p≤0.026)。在两组中,快速强化的血管瘤在PVP期表现为完全强化或进行性不完全强化,在TP期持续或转变为伪廓清,而缓慢强化的血管瘤在PVP期和TP期均表现为进行性不完全强化。肝实质的SNR持续上升直至TP期,而门静脉和血管瘤的SNR在TP期下降。

结论

无论是否存在CLD,快速强化的血管瘤在TP期出现伪廓清的情况比缓慢强化的血管瘤更常见,且两个亚组的强化模式不同。

关键点

在钆塞酸二钠增强MRI上,一些肝血管瘤在移行期出现伪廓清。无论是否患有慢性肝病,快速强化的血管瘤中伪廓清明显更常见。快速强化的血管瘤在TP期表现为完全强化、进行性不完全强化或伪廓清。缓慢强化的血管瘤在门静脉期和TP期表现为进行性不完全强化。

相似文献

1
Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI.钆塞酸二钠增强肝脏MRI上肝血管瘤的强化模式及假性廓清
Eur Radiol. 2016 Jan;26(1):191-8. doi: 10.1007/s00330-015-3798-9. Epub 2015 May 2.
2
Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.钆塞酸二钠增强肝脏MRI上原发性肝血管肉瘤的影像学表现:与相似大小的肝血管瘤比较
Clin Radiol. 2018 Mar;73(3):244-253. doi: 10.1016/j.crad.2017.09.015. Epub 2017 Oct 27.
3
Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign.使用钆塞酸二钠进行肝脏磁共振成像时鉴别肝血管瘤与转移瘤:延迟廓清征的价值
Eur J Radiol. 2016 Mar;85(3):635-40. doi: 10.1016/j.ejrad.2015.12.028. Epub 2016 Jan 4.
4
Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.肝血管瘤:钆塞酸二钠动态 MRI 增强模式评估。
AJR Am J Roentgenol. 2011 Apr;196(4):824-30. doi: 10.2214/AJR.10.5113.
5
High-flow haemangiomas versus hypervascular hepatocellular carcinoma showing "pseudo-washout" on gadoxetic acid-enhanced hepatic MRI: value of diffusion-weighted imaging in the differential diagnosis of small lesions.钆塞酸增强肝脏磁共振成像上表现为“假性廓清”的高流量血管瘤与高血供肝细胞癌:扩散加权成像在小病灶鉴别诊断中的价值
Clin Radiol. 2017 Mar;72(3):247-254. doi: 10.1016/j.crad.2016.09.020. Epub 2016 Oct 24.
6
Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.钆塞酸二钠增强肝脏 MRI:肝脏实质和门静脉的剂量依赖性对比动态。
AJR Am J Roentgenol. 2011 Jan;196(1):W18-24. doi: 10.2214/AJR.10.4387.
7
Hepatic enhancement in cirrhosis in the portal venous phase: what are the differences between gadoxetate disodium and gadobenate dimeglumine?肝硬化患者门静脉期肝实质增强:钆塞酸二钠与钆贝葡胺有何不同?
Abdom Radiol (NY). 2020 Aug;45(8):2409-2417. doi: 10.1007/s00261-020-02578-4.
8
Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.肝血管瘤与转移瘤的鉴别:钆塞酸二钠增强 3.0T MRI 表现
AJR Am J Roentgenol. 2010 Oct;195(4):941-6. doi: 10.2214/AJR.09.3730.
9
Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.影响肝胆期特异性对比剂增强肝脏 MRI 肝癌显示的生物学因素。
AJR Am J Roentgenol. 2013 Aug;201(2):322-31. doi: 10.2214/AJR.12.9478.
10
Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.在慢性肝病患者中,钆塞酸二钠给药后肝胆期肝脏增强:实验室因素的作用。
J Magn Reson Imaging. 2011 Aug;34(2):301-9. doi: 10.1002/jmri.22635. Epub 2011 May 23.

引用本文的文献

1
Gadoxetic acid-enhanced MRI in hepatocellular carcinoma: a comprehensive review of diagnostic, surveillance, and treatment response prediction and assessment.钆塞酸二钠增强磁共振成像在肝细胞癌中的应用:诊断、监测及治疗反应预测与评估的全面综述
Jpn J Radiol. 2025 Sep 15. doi: 10.1007/s11604-025-01870-x.
2
Clinical Significance of Liver MR Imaging.肝脏磁共振成像的临床意义。
Magn Reson Med Sci. 2023 Apr 1;22(2):157-175. doi: 10.2463/mrms.rev.2022-0100. Epub 2023 Feb 1.
3
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

本文引用的文献

1
Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.钆塞酸二钠增强磁共振成像与增强 CT 对肝血管瘤的影像学特征比较。
World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.
2
Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.肝脏 Gd-EOB-DTPA 增强 MRI 肝胆期外周低信号影:诊断陷阱肝血管瘤。
J Magn Reson Imaging. 2012 Apr;35(4):852-8. doi: 10.1002/jmri.23514. Epub 2011 Nov 29.
3
Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging.
肝脏假病灶和良性病灶的形态学、动态及功能特征
Radiol Med. 2022 Feb;127(2):129-144. doi: 10.1007/s11547-022-01449-w. Epub 2022 Jan 13.
4
Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?钆塞酸增强 MRI 用于诊断慢性肝病患者肝细胞癌:门静脉晚期低信号可以替代廓清吗?
Abdom Radiol (NY). 2020 Sep;45(9):2705-2716. doi: 10.1007/s00261-020-02553-z.
5
Imaging of hepatic hemangioma: from A to Z.肝血管瘤的影像学表现:从 A 到 Z。
Abdom Radiol (NY). 2020 Mar;45(3):672-691. doi: 10.1007/s00261-019-02294-8.
6
Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.肝细胞癌及其类似物的不典型表现:如何使用钆塞酸增强肝脏磁共振成像解决具有挑战性的病例。
Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636.
7
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.钆塞酸增强磁共振成像:肝细胞癌及类似病变。
Clin Mol Hepatol. 2019 Sep;25(3):223-233. doi: 10.3350/cmh.2018.0107. Epub 2019 Jan 21.
8
Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.钆塞酸二钠增强MRI对不同直径的LI-RADS 4类肝细胞癌结节的诊断效能
Oncol Lett. 2018 Aug;16(2):2725-2731. doi: 10.3892/ol.2018.8884. Epub 2018 Jun 4.
9
Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command.培训技术人员使用简单且更适应患者的呼吸指令后,钆塞酸增强 MRI 上呼吸运动伪影减少。
Eur Radiol. 2016 Aug;26(8):2714-22. doi: 10.1007/s00330-015-4086-4. Epub 2015 Nov 16.
钆塞酸二钠增强磁共振成像定量评估肝功能。
Radiology. 2011 Sep;260(3):727-33. doi: 10.1148/radiol.11100586. Epub 2011 Jun 28.
4
Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.使用钆塞酸增强磁共振成像鉴别肝转移瘤和肝血管瘤。
Invest Radiol. 2011 Jun;46(6):359-65. doi: 10.1097/RLI.0b013e3182104b77.
5
Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.肝血管瘤:钆塞酸二钠动态 MRI 增强模式评估。
AJR Am J Roentgenol. 2011 Apr;196(4):824-30. doi: 10.2214/AJR.10.5113.
6
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.检测和描述肝脏局灶性病变:一项日本 III 期、多中心的钆塞酸二钠增强磁共振成像与增强计算机断层扫描对比研究,主要针对肝细胞癌和慢性肝病患者。
Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.
7
"Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.钆塞酸二钠增强 MRI 上高流量肝血管瘤的“假性洗脱”征象,类似于富血管性肿瘤。
AJR Am J Roentgenol. 2009 Dec;193(6):W490-6. doi: 10.2214/AJR.08.1732.
8
Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.腹部实体器官及大血管的动态对比增强磁共振成像:钆塞酸二钠与钆喷酸葡胺增强效果的比较
J Magn Reson Imaging. 2009 Mar;29(3):636-40. doi: 10.1002/jmri.21689.
9
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.钆塞酸二钠(普美显)增强磁共振成像和螺旋CT对治疗策略的诊断效能:与肝脏局灶性病变的术中及组织病理学结果比较
Eur Radiol. 2008 Mar;18(3):457-67. doi: 10.1007/s00330-007-0716-9. Epub 2007 Dec 6.
10
Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations.钆塞酸增强磁共振成像中肝脏局灶性病变的强化:与组织病理学结果及螺旋CT的相关性——初步观察
Radiology. 2005 Feb;234(2):468-78. doi: 10.1148/radiol.2342040278. Epub 2004 Dec 10.